+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Moderate to Severe Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate to Severe Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Mucopolysaccharidosis I - Pipeline Insight, 2024 - Product Thumbnail Image

Mucopolysaccharidosis I - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Mucopolysaccharidosis II - Pipeline Insight, 2024 - Product Thumbnail Image

Mucopolysaccharidosis II - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Papulopustular Rosacea - Pipeline Insight, 2024 - Product Thumbnail Image

Papulopustular Rosacea - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Severe Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Severe Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Birch Pollen Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Chronic Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
Otitis media - Pipeline Insight, 2024 - Product Thumbnail Image

Otitis media - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Peanut Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Peanut Allergy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Primary Immune Deficiency (PID) - Pipeline Insight, 2024 - Product Thumbnail Image

Primary Immune Deficiency (PID) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Systemic Mastocytosis - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Mastocytosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Moderate Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Axial Spondyloarthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Axial Spondyloarthritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Seasonal Allergic Rhinitis - Pipeline Insight, 2024 - Product Thumbnail Image

Seasonal Allergic Rhinitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Rosacea - Pipeline Insight, 2024 - Product Thumbnail Image

Rosacea - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Rhinosinusitis - Pipeline Insight, 2024 - Product Thumbnail Image

Rhinosinusitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Contact Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Febrile Neutropenia - Pipeline Insight, 2024 - Product Thumbnail Image

Febrile Neutropenia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 65 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more